MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,184 | +52.9% | 14,490 | +26.9% | 0.01% | +66.7% |
| Q2 2023 | $412,677 | -5.0% | 11,422 | -2.2% | 0.00% | -25.0% |
| Q1 2023 | $434,262 | -12.7% | 11,680 | +6.3% | 0.00% | -20.0% |
| Q4 2022 | $497,685 | -32.6% | 10,984 | +4.0% | 0.01% | -37.5% |
| Q3 2022 | $738,000 | +4.4% | 10,563 | +0.4% | 0.01% | +14.3% |
| Q2 2022 | $707,000 | -17.7% | 10,526 | +0.7% | 0.01% | 0.0% |
| Q1 2022 | $859,000 | -39.8% | 10,448 | +7.4% | 0.01% | -36.4% |
| Q4 2021 | $1,427,000 | -17.8% | 9,726 | -0.8% | 0.01% | -21.4% |
| Q3 2021 | $1,735,000 | +11.5% | 9,808 | +1.8% | 0.01% | +7.7% |
| Q2 2021 | $1,556,000 | -11.3% | 9,635 | -6.0% | 0.01% | -13.3% |
| Q1 2021 | $1,755,000 | -4.8% | 10,246 | +22.0% | 0.02% | -11.8% |
| Q4 2020 | $1,844,000 | +29.8% | 8,396 | -1.9% | 0.02% | +21.4% |
| Q3 2020 | $1,421,000 | +95.2% | 8,559 | +34.2% | 0.01% | +40.0% |
| Q2 2020 | $728,000 | +57.2% | 6,379 | +6.0% | 0.01% | +25.0% |
| Q1 2020 | $463,000 | – | 6,018 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |